Shenzhen Kiuzou Medical Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Kiuzou Medical Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KIUZOU. The owner is based in Shenzhen.

1302, No.2,Zhenye Road,Liulian Community

Pingshan street, Pingshan district

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KIUZOU
KIUZOU
Registered 2019

Trademark Classifications

Shenzhen Kiuzou Medical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Kiuzou Medical Technology Co., Ltd. have?

Shenzhen Kiuzou Medical Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Kiuzou Medical Technology Co., Ltd. file in?

Shenzhen Kiuzou Medical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Kiuzou Medical Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Kiuzou Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as KIUZOU. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Kiuzou Medical Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Kiuzou Medical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.